Quadrivalent HPV (4vHPV) vaccine immunogenicity and safety in women using immunosuppressive drugs due to solid organ transplant
4vHPV vaccine was well-tolerated by SOT recipients. We found strong evidence of lower humoral immune responses to 4vHPV vaccine in SOT compared to immunocompetent women, which strengthen recommendation of routine cervical cancer screening in SOT recipients regardless of HPV vaccination status.
Authors
- Vanessa Infante (ORCID: https://orcid.org/0000-0002-1812-5122)
- Philippe Mayaud (ORCID: https://orcid.org/0000-0001-5730-947X)
- Karina Takesaki Miyaji (ORCID: https://orcid.org/0000-0003-2653-3975)
- Joakim Dillner (ORCID: https://orcid.org/0000-0001-8588-6506)
- José Eduardo Levi (ORCID: https://orcid.org/0000-0002-3557-2717)
- Hanna Kann (ORCID: https://orcid.org/0000-0003-2014-5437)
- Ana Marli Christovam Sartori (ORCID: https://orcid.org/0000-0003-3777-0757)
- Carina Eklund
- Amanda Nazareth Lara (ORCID: https://orcid.org/0000-0002-4294-0282)
- Cristina Paula Castanheira
- Camila de Melo Picone (ORCID: https://orcid.org/0000-0002-2455-5831)
- Maricy Tacla (ORCID: https://orcid.org/0000-0002-2712-2724)
- Ana Carolina Soares de Oliveira
- Lyca Suzuki Kawakami
Institutions
- Karolinska Institutet (SE)
- London School of Hygiene & Tropical Medicine (GB)
- Instituto de Medicina Avançada (BR)
- Instituto de Medicina Tropical (PY)
- Hospital das Clínicas da Faculdade de Medicina da Universidade de São Paulo (BR)
- University of Gothenburg (SE)
Publication Details
- Journal
- Frontiers in Cellular and Infection Microbiology
- Published
- 2024-11-04
- DOI
- https://doi.org/10.3389/fcimb.2024.1452916
- Citations
- 4
- Primary Topic
- Cervical Cancer and HPV Research
- Type
- article
- Field-Weighted Citation Impact
- 1.55
Funders
- Karolinska Institutet
- Faculdade de Medicina da Universidade de São Paulo